These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26522049)

  • 41. Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications.
    Tsochandaridis M; Nasca L; Toga C; Levy-Mozziconacci A
    Biomed Res Int; 2015; 2015():294954. PubMed ID: 25699269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating microRNA expression profiles in ovarian cancer.
    Ayaz L; Çayan F; Balci Ş; Görür A; Akbayir S; Yıldırım Yaroğlu H; Doğruer Unal N; Tamer L
    J Obstet Gynaecol; 2014 Oct; 34(7):620-4. PubMed ID: 24911418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deep sequencing, profiling and detailed annotation of microRNAs in Takifugu rubripes.
    Wongwarangkana C; Fujimori KE; Akiba M; Kinoshita S; Teruya M; Nezuo M; Masatoshi T; Watabe S; Asakawa S
    BMC Genomics; 2015 Jun; 16(1):457. PubMed ID: 26078057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The stability and persistence of blood and semen mRNA and miRNA targets for body fluid identification in environmentally challenged and laundered samples.
    Mayes C; Houston R; Seashols-Williams S; LaRue B; Hughes-Stamm S
    Leg Med (Tokyo); 2019 May; 38():45-50. PubMed ID: 30959396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating microRNAs.
    Makarova JA; Shkurnikov MU; Turchinovich AA; Tonevitsky AG; Grigoriev AI
    Biochemistry (Mosc); 2015 Sep; 80(9):1117-26. PubMed ID: 26555465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs as biomarkers in pituitary tumors.
    Di Ieva A; Butz H; Niamah M; Rotondo F; De Rosa S; Sav A; Yousef GM; Kovacs K; Cusimano MD
    Neurosurgery; 2014 Aug; 75(2):181-9; discussion 188-9. PubMed ID: 24739366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J; Nema V; Dhas Y; Mishra N
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miRNAs Regulation and Its Role as Biomarkers in Endometriosis.
    Marí-Alexandre J; Sánchez-Izquierdo D; Gilabert-Estellés J; Barceló-Molina M; Braza-Boïls A; Sandoval J
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNAs: potential biomarkers for disease diagnosis.
    Xu L; Qi X; Duan S; Xie Y; Ren X; Chen G; Yang X; Han L; Dong Q
    Biomed Mater Eng; 2014; 24(6):3917-25. PubMed ID: 25227110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Cell Signal; 2013 Sep; 25(9):1828-36. PubMed ID: 23707525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.
    Cortez MA; Calin GA
    Expert Opin Biol Ther; 2009 Jun; 9(6):703-711. PubMed ID: 19426115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?
    Nair N; Gupta S; Collier IX; Gongora E; Vijayaraghavan K
    Int J Cardiol; 2014 Aug; 175(3):395-9. PubMed ID: 25002320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.
    Keller A; Backes C; Leidinger P; Kefer N; Boisguerin V; Barbacioru C; Vogel B; Matzas M; Huwer H; Katus HA; Stähler C; Meder B; Meese E
    Mol Biosyst; 2011 Dec; 7(12):3187-99. PubMed ID: 22027949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-analytical variables in miRNA analysis.
    Becker N; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):861-8. PubMed ID: 23466658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methodological challenges in utilizing miRNAs as circulating biomarkers.
    Moldovan L; Batte KE; Trgovcich J; Wisler J; Marsh CB; Piper M
    J Cell Mol Med; 2014 Mar; 18(3):371-90. PubMed ID: 24533657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular microRNAs in urologic malignancies: chances and challenges.
    Huang X; Liang M; Dittmar R; Wang L
    Int J Mol Sci; 2013 Jul; 14(7):14785-99. PubMed ID: 23863690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.